Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cruz-Teran

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 23, 2020
Challenges & opportunities for phage-based in situ microbiome engineering in the gutPeter J Voorhees, Carlos Cruz-Teran, Jasmine Edelstein, et al.
ACS Omega|July 25, 2022
Experimental and Analytical Framework for "Mix-and-Read" Assays Based on Split LuciferaseNikki McArthur, Carlos Cruz-Teran, Apoorva Thatavarty, et al.
Advanced Drug Delivery Reviews|December 14, 2020
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapyCarlos Cruz-Teran, Karthik Tiruthani, Morgan McSweeney, et al.
ACS Nano|March 12, 2024
Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in SwineLimei Shen, Zhongbo Li, Alice Ma, et al.
Bioengineering & Translational Medicine|July 22, 2024
Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19Karthik Tiruthani, Carlos Cruz-Teran, Jasper F W Chan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 23, 2020
Challenges & opportunities for phage-based in situ microbiome engineering in the gutPeter J Voorhees, Carlos Cruz-Teran, Jasmine Edelstein, et al.
ACS Omega|July 25, 2022
Experimental and Analytical Framework for "Mix-and-Read" Assays Based on Split LuciferaseNikki McArthur, Carlos Cruz-Teran, Apoorva Thatavarty, et al.
Advanced Drug Delivery Reviews|December 14, 2020
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapyCarlos Cruz-Teran, Karthik Tiruthani, Morgan McSweeney, et al.
ACS Nano|March 12, 2024
Free PEG Suppresses Anaphylaxis to PEGylated Nanomedicine in SwineLimei Shen, Zhongbo Li, Alice Ma, et al.
Bioengineering & Translational Medicine|July 22, 2024
Engineering a "muco-trapping" ACE2-immunoglobulin hybrid with picomolar affinity as an inhaled, pan-variant immunotherapy for COVID-19Karthik Tiruthani, Carlos Cruz-Teran, Jasper F W Chan, et al.
Pageof 1